276 related articles for article (PubMed ID: 15128409)
1. The Type IV phosphodiesterase inhibitor rolipram interferes with drug-induced conditioned place preference but not immediate early gene induction in mice.
Thompson BE; Sachs BD; Kantak KM; Cherry JA
Eur J Neurosci; 2004 May; 19(9):2561-8. PubMed ID: 15128409
[TBL] [Abstract][Full Text] [Related]
2. The involvement of type IV phosphodiesterases in cocaine-induced sensitization and subsequent pERK expression in the mouse nucleus accumbens.
Janes AC; Kantak KM; Cherry JA
Psychopharmacology (Berl); 2009 Oct; 206(2):177-85. PubMed ID: 19588125
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
4. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats.
Makhay MM; Houslay MD; O'Donnell JM
Psychopharmacology (Berl); 2001 Nov; 158(3):297-304. PubMed ID: 11713620
[TBL] [Abstract][Full Text] [Related]
6. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus.
Núñez C; González-Cuello A; Sánchez L; Vargas ML; Milanés MV; Laorden ML
Eur J Pharmacol; 2009 Oct; 620(1-3):1-8. PubMed ID: 19683523
[TBL] [Abstract][Full Text] [Related]
7. In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor.
Foissier L; Lonchampt M; Cogé F; Canet E
J Pharmacol Exp Ther; 1996 Sep; 278(3):1484-90. PubMed ID: 8819536
[TBL] [Abstract][Full Text] [Related]
8. Effects of urokinase-type plasminogen activator in the acquisition, expression and reinstatement of cocaine-induced conditioned-place preference.
Bahi A; Kusnecov AW; Dreyer JL
Behav Brain Res; 2008 Aug; 191(1):17-25. PubMed ID: 18436315
[TBL] [Abstract][Full Text] [Related]
9. Additive effects of intra-accumbens infusion of the cAMP-specific phosphodiesterase inhibitor, rolipram and cocaine on brain stimulation reward.
Knapp CM; Lee K; Foye M; Ciraulo DA; Kornetsky C
Life Sci; 2001 Aug; 69(14):1673-82. PubMed ID: 11589507
[TBL] [Abstract][Full Text] [Related]
10. Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition.
Oger S; Behr-Roussel D; Gorny D; Denys P; Lebret T; Alexandre L; Giuliano F
Eur Urol; 2007 Mar; 51(3):772-80; discussion 780-1. PubMed ID: 17097801
[TBL] [Abstract][Full Text] [Related]
11. Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
Mamiya T; Noda Y; Ren X; Hamdy M; Furukawa S; Kameyama T; Yamada K; Nabeshima T
Br J Pharmacol; 2001 Mar; 132(5):1111-7. PubMed ID: 11226142
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors.
Méhats C; Tanguy G; Paris B; Robert B; Pernin N; Ferré F; Leroy MJ
J Pharmacol Exp Ther; 2000 Feb; 292(2):817-23. PubMed ID: 10640323
[TBL] [Abstract][Full Text] [Related]
13. Altered Fos expression in neural pathways underlying cue-elicited drug seeking in the rat.
Miller CA; Marshall JF
Eur J Neurosci; 2005 Mar; 21(5):1385-93. PubMed ID: 15813948
[TBL] [Abstract][Full Text] [Related]
14. Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.
Harada D; Tsukumo Y; Takashima Y; Manabe H
Eur J Pharmacol; 2006 Feb; 532(1-2):128-37. PubMed ID: 16442096
[TBL] [Abstract][Full Text] [Related]
15. The type IV phosphodiesterase inhibitor rolipram disturbs expression and extinction of conditioned fear in mice.
Mueller EM; Hofmann SG; Cherry JA
Neuropharmacology; 2010; 59(1-2):1-8. PubMed ID: 20362594
[TBL] [Abstract][Full Text] [Related]
16. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor.
Aoki M; Fukunaga M; Sugimoto T; Hirano Y; Kobayashi M; Honda K; Yamada T
J Pharmacol Exp Ther; 2001 Sep; 298(3):1142-9. PubMed ID: 11504812
[TBL] [Abstract][Full Text] [Related]
17. Specific type IV phosphodiesterase inhibitor ameliorates cerulein-induced pancreatitis in rats.
Sato T; Otaka M; Odashima M; Kato S; Jin M; Konishi N; Matsuhashi T; Watanabe S
Biochem Biophys Res Commun; 2006 Jul; 346(1):339-44. PubMed ID: 16759642
[TBL] [Abstract][Full Text] [Related]
18. A selective phosphodiesterase IV inhibitor, rolipram blocks both withdrawal behavioral manifestations, and c-Fos protein expression in morphine dependent mice.
Hamdy MM; Mamiya T; Noda Y; Sayed M; Assi AA; Gomaa A; Yamada K; Nabeshima T
Behav Brain Res; 2001 Jan; 118(1):85-93. PubMed ID: 11163637
[TBL] [Abstract][Full Text] [Related]
19. Difference in preventive effects between the phosphodiesterase iv inhibitor rolipram and anti-arthritic drugs on antigen-induced arthritis in mice.
Yamaki K; Li X; Hossain MA; Alam AH; Taneda S; Yanagisawa R; Takano H; Yoshino S
Immunol Invest; 2007; 36(2):131-45. PubMed ID: 17365015
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart.
González-Cuello A; Sánchez L; Hernández J; Teresa Castells M; Victoria Milanés M; Laorden ML
Eur J Pharmacol; 2007 Sep; 570(1-3):1-9. PubMed ID: 17601555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
